ArticleChemistry & biodiversity2026
Neuroprotective and Renoprotective Potential of a Hydroethanolic Extract From the Aerial Parts of Mattiastrum paphlagonicum Bornm. (Boraginaceae).
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study provides an analysis of the endemic plant Mattiastrum paphlagonicum Bornm.(Synonym Paracaryum paphlagonicum (Bornm.) R.R. Mill), focusing on enzyme activity, secondary metabolite content, antioxidant capacity (DPPH, ABTS, and FRAP), as well as phenolic and flavonoid levels, all within the context of a hydroethanolic extract prepared from M. paphlagonicum and its biodiversity, for the first time. Rosmarinic acid and rutin were identified at concentrations of 87.56 ± 0.09 and 0.96 ± 0.15 mg/g of the plant extract, respectively. The total polyphenol and flavonoid contents were measured as 0.85 ± 0.004 mg gallic acid equivalent/mL and 0.077 ± 0.014 mg rutin equivalent/mL. The extract exhibited exceptionally strong DPPH radical-scavenging activity, with a value of 231.746 ± 0.009 mg ascorbic acid equivalents (AAE)/mL extract, and high ferric reducing antioxidant power (FRAP), reaching 168.229 ± 0.004 mg AAE/mL extract. The percentage inhibition for tyrosinase and carbonic anhydrase by the extract was 97.6 ± 0.011% and 77.07 ± 0.996%, respectively. The extract is a rich source of bioactive compounds and has considerable inhibitory effects on tyrosinase and carbonic anhydrase enzymes. These findings highlight the plant's potential for neuroprotective and renoprotective pharmacological applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.